S. 4472 is a bill that aims to extend the provisions of the Accelerating Access to Critical Therapies for ALS Act, allowing for continued support and funding for research and treatment related to Amyotrophic Lateral Sclerosis (ALS) through the fiscal year 2031. The bill seeks to ensure that patients have access to critical therapies and that ongoing research can be funded adequately.
The reauthorization of the Accelerating Access to Critical Therapies for ALS Act through S. 4472 has been received positively in the media, with many praising the commitment to supporting ALS research and therapies. Advocates for ALS patients have highlighted the importance of this legislation in providing hope and resources for those affected by the disease.
Critics of S. 4472 have raised concerns about the effectiveness of the current provisions of the Accelerating Access to Critical Therapies for ALS Act, arguing that simply extending funding without substantial reforms may not lead to significant advancements in treatment. Some media outlets have pointed out potential shortcomings in the bill's approach to addressing the urgent needs of ALS patients.
The analysis of Bill S. 4472, which aims to reauthorize the Accelerating Access to Critical Therapies for ALS Act, reveals no direct industry overlaps between the sponsor, Lisa Murkowski, and her top donor industries. The lobbying activity in the bill's policy area includes a variety of organizations, but none appear to directly influence the bill's subject matter related to ALS therapies. The highest reported lobbying amount is $110,000 from BAMCO LLC, which does not have a clear connection to ALS therapies. Given the absence of direct financial ties to the bill's focus, the risk of conflict of interest remains low. Voters should be aware that while lobbying exists, it does not directly correlate with the interests of the bill.
Organizations that lobbied on issues related to this bill's policy area.
| Client | Lobbying Firm | Amount |
|---|---|---|
| BAMCO LLC | CHECKMATE GOVERNMENT RELATIONS | $110,000 |
| TRANSPORTATION COMMUNICATIONS NATIONAL UNION/IAM (FKA TRANSPORTATION COMMUNICATI | TRANSPORTATION COMMUNICATIONS NATIONAL UNION/IAM (FKA TRANSPORTATION COMMUNICATI | $70,000 |
| MCCORMICK & COMPANY, INCORPORATED | MCCORMICK & COMPANY, INCORPORATED | $20,000 |
| AMERICAN ACADEMY OF PEDIATRICS | HARO SOLUTIONS LLC | $10,000 |
| INTERCOMP COMPANY | BROMELKAMP GOVERNMENT RELATIONS, LLC | $10,000 |
| CONSUMER BANKERS ASSOCIATION | 1607 STRATEGIES, LLC | $10,000 |
| NATIONAL ASSOCIATION FOR GIFTED CHILDREN | JENNIFER MADSEN | undisclosed |
| AMERICAN COMMERCIAL BARGE LINE LLC | AMERICAN COMMERCIAL BARGE LINES, LLC | undisclosed |
| GALVANIZE THERAPEUTICS, INC. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | undisclosed |
| NEURALINK CORP. | JEFFREY J. KIMBELL & ASSOCIATES, INC. | undisclosed |
| CAPITOL COUNSEL LLC ON BEHALF OF SKYVAULT AI LLC | MICHAEL J. LAMOUREUX | undisclosed |
| PRECISION IMPACTS, LLC | THORN RUN PARTNERS | undisclosed |
| CITY OF FREDERICK OKLAHOMA | BROMELKAMP GOVERNMENT RELATIONS, LLC | undisclosed |
| TWINLOGIC STRATEGIES ON BEHALF OF PEW CHARITABLE TRUSTS | WINN STRATEGIES, LLC | undisclosed |
| MONUMENT HILLS PARTNERS, LLC | THE BERNHARDT GROUP LLC | undisclosed |
Source: Senate Lobbying Disclosure Act (LDA) filings, 2026
Top industries funding Lisa Murkowski, ranked by total contributions.
Source: OpenSecrets.org (Center for Responsive Politics)
